Eisai Co., Ltd - Strategy, SWOT and Corporate Finance Report
Summary
Eisai Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Eisai Co., Ltd. (Eisai or 'the company') is a manufacturer of pharmaceutical products. The company also involved in research and development, sale and import and export of pharmaceutical products including prescription medicines, over-the-counterover the counter (OTC) drugs and generics. Its major products include Aricept, an anti-Alzheimer's agent; Pariet/AcipHex (proton pump inhibitor); Fycompa, an anti-epileptic, Halaven, a novel anti-cancer agent; and peripheral neuropathy treatment, among others. The companyIt manufactures products related to neurology and oncology areas. The company operates its manufacturing plants in the UK, China, India and Japan. EisaiIt primarily operates in Japan, the Americas, EMEA (Europe, the Middle East, Africa, Russia and Oceania), Asia and Latin America. The company is headquartered in Tokyo, Japan
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook